[144] Xos, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for XOS, Inc. (XOS) discloses a proposed sale of 14,347 shares of common stock through UBS Financial Services on the NASDAQ, with an aggregate market value of $43,041. The filing lists 8,029,000 shares outstanding and an approximate sale date of 08/18/2025.

The shares to be sold were acquired by the holder through restricted stock unit vesting: 4,591 shares vested on 05/30/2023 and 9,756 shares vested on 06/12/2024. The filer reports no securities sold in the past three months and affirms they are not aware of undisclosed material adverse information about the issuer.

Positive

• Planned sale is fully disclosed with broker (UBS) and exchange (NASDAQ) named
• Acquisition source specified (RSU vesting on 05/30/2023 and 06/12/2024), supporting transparency

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; small percentage of outstanding shares set to be sold through a broker.

The Form 144 is a standard regulatory notice indicating an intended sale by an affiliate or insider. The filing specifies broker details (UBS Financial Services), the number of shares (14,347) and an aggregate market value ($43,041). The shares were received via RSU vesting across two dates in 2023 and 2024, which is common for equity compensation. No prior sales in the past three months are reported, suggesting this is not part of a rapid divestiture. Overall, the filing provides necessary disclosure but does not, by itself, indicate material impact to the company given the size disclosed.

Corporate Governance Expert

TL;DR: Proper compliance with Rule 144 procedures; filer certified absence of undisclosed material information.

The notice includes the required statements about the source of shares (RSU vesting) and contains the filers representation that no material, nonpublic adverse information is known. Broker and exchange details are included, and the filer indicated no securities sold in the last three months. This aligns with standard governance and insider-trading disclosure practices. The filing does not reveal governance changes or material corporate events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	14347	43041	8029000	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/30/2023	RSU Vesting	Issuer			4591	05/30/2023	NA
Common Stock	06/12/2024	RSU Vesting	Issuer			9756	06/12/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does XOS's Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 14,347 shares of common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $43,041.

When is the approximate sale date for the XOS shares?

The approximate date of sale listed is 08/18/2025.

How were the XOS shares being sold acquired?

The shares were acquired via RSU vesting: 4,591 shares on 05/30/2023 and 9,756 shares on 06/12/2024.

Has the filer sold any XOS securities in the past three months?

The filing reports Nothing to Report for securities sold during the past three months.

What statement does the filer make about material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.